Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination

Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no compl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Krisly Arguedas Vásquez, Valverde, Erick Miranda, Aguilar, Daniel Valerio, Henri-Jacques Hernández Gabarain
Format:	Dataset
Sprache:	eng
Schlagworte:	FOS: Clinical medicine FOS: Health sciences FOS: Psychology Geriatrics and Gerontology Health Care Administration Medicine Neurology and Neuromuscular Diseases Nursing not elsewhere classified Psychiatry (incl. Psychotherapy) Psychology not elsewhere classified
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Krisly Arguedas Vásquez Valverde, Erick Miranda Aguilar, Daniel Valerio Henri-Jacques Hernández Gabarain
description	Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.
doi_str_mv	10.6084/m9.figshare.7941260
format	Dataset
fullrecord	<record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_7941260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_7941260</sourcerecordid><originalsourceid>FETCH-LOGICAL-d890-7eec2a4cc110a00cc24258289a4a67cb46e8f4bc0798ad8de64751f1f6a54d653</originalsourceid><addsrcrecordid>eNo1kMtOwzAQRbNhgQpfwMY_kGInjuMsq1IeUiuQ6N6aOpN2ROJUHovHhm8nVcvqSvfqnsXJsjsl50ZafT808472fICI87rRqjDyOvvdjCFFhF4sx32gRJ8oFszIPGBIgj30KCiIIySaChZflA7iDeIHBR6DeCBGYDzXYYzDRGI_RuTTKx1QbChQvpm-0_KeIKFYfcNAYQKO4Sa76qBnvL3kLNs-rrbL53z9-vSyXKzz1jYyrxF9Adp7pSRI6X2hi8oWtgENpvY7bdB2eudl3VhobYtG15XqVGeg0q2pyllWnrEtJPCU0B0jDRB_nJLuJMcNjfuX4y5yyj_vl2N3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination</title><source>DataCite</source><creator>Krisly Arguedas Vásquez ; Valverde, Erick Miranda ; Aguilar, Daniel Valerio ; Henri-Jacques Hernández Gabarain</creator><creatorcontrib>Krisly Arguedas Vásquez ; Valverde, Erick Miranda ; Aguilar, Daniel Valerio ; Henri-Jacques Hernández Gabarain</creatorcontrib><description>Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.</description><identifier>DOI: 10.6084/m9.figshare.7941260</identifier><language>eng</language><publisher>SciELO journals</publisher><subject>FOS: Clinical medicine ; FOS: Health sciences ; FOS: Psychology ; Geriatrics and Gerontology ; Health Care Administration ; Medicine ; Neurology and Neuromuscular Diseases ; Nursing not elsewhere classified ; Psychiatry (incl. Psychotherapy) ; Psychology not elsewhere classified</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.7941260$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Krisly Arguedas Vásquez</creatorcontrib><creatorcontrib>Valverde, Erick Miranda</creatorcontrib><creatorcontrib>Aguilar, Daniel Valerio</creatorcontrib><creatorcontrib>Henri-Jacques Hernández Gabarain</creatorcontrib><title>Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination</title><description>Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.</description><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>FOS: Psychology</subject><subject>Geriatrics and Gerontology</subject><subject>Health Care Administration</subject><subject>Medicine</subject><subject>Neurology and Neuromuscular Diseases</subject><subject>Nursing not elsewhere classified</subject><subject>Psychiatry (incl. Psychotherapy)</subject><subject>Psychology not elsewhere classified</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2019</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kMtOwzAQRbNhgQpfwMY_kGInjuMsq1IeUiuQ6N6aOpN2ROJUHovHhm8nVcvqSvfqnsXJsjsl50ZafT808472fICI87rRqjDyOvvdjCFFhF4sx32gRJ8oFszIPGBIgj30KCiIIySaChZflA7iDeIHBR6DeCBGYDzXYYzDRGI_RuTTKx1QbChQvpm-0_KeIKFYfcNAYQKO4Sa76qBnvL3kLNs-rrbL53z9-vSyXKzz1jYyrxF9Adp7pSRI6X2hi8oWtgENpvY7bdB2eudl3VhobYtG15XqVGeg0q2pyllWnrEtJPCU0B0jDRB_nJLuJMcNjfuX4y5yyj_vl2N3</recordid><startdate>20190403</startdate><enddate>20190403</enddate><creator>Krisly Arguedas Vásquez</creator><creator>Valverde, Erick Miranda</creator><creator>Aguilar, Daniel Valerio</creator><creator>Henri-Jacques Hernández Gabarain</creator><general>SciELO journals</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20190403</creationdate><title>Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination</title><author>Krisly Arguedas Vásquez ; Valverde, Erick Miranda ; Aguilar, Daniel Valerio ; Henri-Jacques Hernández Gabarain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d890-7eec2a4cc110a00cc24258289a4a67cb46e8f4bc0798ad8de64751f1f6a54d653</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2019</creationdate><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>FOS: Psychology</topic><topic>Geriatrics and Gerontology</topic><topic>Health Care Administration</topic><topic>Medicine</topic><topic>Neurology and Neuromuscular Diseases</topic><topic>Nursing not elsewhere classified</topic><topic>Psychiatry (incl. Psychotherapy)</topic><topic>Psychology not elsewhere classified</topic><toplevel>online_resources</toplevel><creatorcontrib>Krisly Arguedas Vásquez</creatorcontrib><creatorcontrib>Valverde, Erick Miranda</creatorcontrib><creatorcontrib>Aguilar, Daniel Valerio</creatorcontrib><creatorcontrib>Henri-Jacques Hernández Gabarain</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Krisly Arguedas Vásquez</au><au>Valverde, Erick Miranda</au><au>Aguilar, Daniel Valerio</au><au>Henri-Jacques Hernández Gabarain</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination</title><date>2019-04-03</date><risdate>2019</risdate><abstract>Several screening tests have been used for cognitive evaluation in Parkinson’s disease (PD). Objective: To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease and no cognitive impairment complaints. Methods: A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered. Results: 80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups. Conclusion: The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.</abstract><pub>SciELO journals</pub><doi>10.6084/m9.figshare.7941260</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	DOI: 10.6084/m9.figshare.7941260
ispartof
issn
language	eng
recordid	cdi_datacite_primary_10_6084_m9_figshare_7941260
source	DataCite
subjects	FOS: Clinical medicine FOS: Health sciences FOS: Psychology Geriatrics and Gerontology Health Care Administration Medicine Neurology and Neuromuscular Diseases Nursing not elsewhere classified Psychiatry (incl. Psychotherapy) Psychology not elsewhere classified
title	Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A21%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Krisly%20Arguedas%20V%C3%A1squez&rft.date=2019-04-03&rft_id=info:doi/10.6084/m9.figshare.7941260&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_7941260%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true